Letermovir
Disease Related To Transplantation
Fernanda P Silveira, MD, MSSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
13 Active assets in the Disease Related To Transplantation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tacrolimus University of Illinois at Chicago | Phase 4 | BBB |
Cyclosporin A Fernanda P Silveira, MD, MS | Phase 4 | BBB |
Sirolimus Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 | BBB |
Busulfanum M.D. Anderson Cancer Center | Phase 3 | BB |
Fludarabine M.D. Anderson Cancer Center | Phase 3 | BB |
View all 31 →
Same molecule, other indications
Letermovir is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →